Journals / Astım Allerji İmmünoloji / 2012 / Cilt: 10 - Sayı: 3

The Stevens-Johnson syndrome: Acase report

Stevens-Johnson sendromlu bir olgu sunumu

Pages
158–162
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case of Stevens-Johnson syndrome who responded well to the treatment with systemic steroids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Stevens-Johnson syndrome is a serious systemic disorder in which there are fever, vesicobullous lesions involving the skin and mucous membranes.
📊
Key Findings & Data:It can result as an immune response to an antigen or as a drug reaction.
💡
Conclusion & Impact:Here, we present a case of Stevens-Johnson syndrome who responded well to the treatment with systemic steroids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Stevens-Johnson syndrome is a serious systemic disorder in which there are fever, vesicobullous lesions involving the skin and mucous membranes. It can result as an immune response to an antigen or as a drug reaction. Most often it is considered as an allergic reaction. It is a self-limiting condition which responds to immediate management or may result in fluid loss, sepsis and death. There is no specific treatment for Stevens-Johnson syndrome. Suspected drug discontinuation and supportive therapy is the first step in treatment of StevensJohnson. Systemic steroid use in the treatment of Stevens-Johnson syndrome is a controversial issue. Here, we present a case of Stevens-Johnson syndrome who responded well to the treatment with systemic steroids.

Özet

Stevens-Johnson sendromu yüksek ateş, pürülan konjunktivit, eroziv stomatit ve jeneralize ekzantemli deri lezyonlarıyla karakterize bir hastalıktır. Etyolojisinde çok çeşitli faktörler rol oynamaktadır. Olguların yarısından çoğunda ilaçlar sorumlu olmakla birlikte infeksiyonlar, kimyasallar ve malign hastalıklar da etyolojide rol alabilir. Acil müdahale ile kendini sınırlayabilirken, sepsis veya ölümle de sonuçlanabilir. Stevens-Johnson sendromu için özel bir tedavi yöntemi bulunmamaktadır. Şüphelenilen ilacın kesilmesi tedavide ilk basamaktır ve destek tedavisiyle birlikte Stevens-Johnson sendromu tedavisinin temelini oluşturur. Stevens-Johnson sendromu tedavisinde sistemik steroid kullanımı tartışmalı bir konudur. Sistemik steroid tedavisine çok iyi yanıt veren Stevens-Johnson sendromlu bir olgu sunulmuştur.

🔖

Cite This Article

KÖSE, Ş., YALÇIN, A. D., AKKOÇLU, G. (2012). The Stevens-Johnson syndrome: Acase report. Astım Allerji İmmünoloji, Cilt: 10 - Sayı: 3, 158–162. https://ajindex.com/articles/159699

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-6
  2. Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Medicine 2008;40:129-38
  3. Lam NS, Yang YH, Wang LC, Lin YT, Chiang BL. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect 2004;37:366-70 4. Turhan V, Adam E, Can M, Haznedaroğlu T, Beşirbellioğlu B. Stevens Johnson sendromu. Klinik Bilimler & Doktor 2000;6:33-6
  4. Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taïeb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000;83:347-52
  5. Rappersberger K, Foedinger D. Treatment of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Dermatologic Therapy 2002; 15:397-408
  6. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85
  7. Fritsch PO, Sidoroff A Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000;1:349-60
  8. Sharma VK, Sethuraman G, Minz A. Stevens-Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol 2008;74:238-40
  9. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens- Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000;136:323-7
  10. Serdaroğlu S, Uysal S. Eritema multiforme. Dermatose 2002;1:9-15
  11. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3
  12. Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007;87:144-8
  13. Dicle O, Yılmaz E, Alpsoy E. Stevens-Johnson sendromu ve toksik epidermal nekroliz: Retrospektif bir değerlendirme. Turkderm 2009;43:15-20
  14. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989;115:881-7
  15. Prins C, Kerdel AF, Padilla